Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Acq. announced
Talon Therapeutics, Inc. (TLON) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/19/2013 8-K Quarterly results
07/17/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Spectrum Pharmaceuticals Acquires Talon Therapeutics South San Francisco, Calif., July 17, 2013 – Talon Therapeutics, Inc. today announced that a subsidiary of Spectrum Pharmaceuticals, Inc. entered into an agreement to purchase approximately 89% of the outstanding shares of Talon directly from the Company’s principal stockholders. Spectrum also entered into an agreement with the Company under which the subsidiary of Spectrum will purchase additional shares from the Company that, together with the shares acquired from the Company’s principal stockholders, will represent in excess of 90% of the outstanding shares of Talon, and under which Spectrum will acquire the remaining outstanding shares of Company common stock through a “short-form” merger of the subsidiary of Spectrum into the Compan..."
04/01/2013 8-K Quarterly results
Docs: "Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2012 Financial Results South San Francisco, California, April 1, 2013 - Talon Therapeutics, Inc., , today reported financial results for the fourth quarter and year ended December 31, 2012. 2012 Corporate Highlights ● FDA accelerated approval of Marqibo® for the treatment of Philadelphia chromosome negative adult acute lymphoblastic leukemia patients in second or greater relapse or whose disease has progressed following two or more prior lines of anti-leukemia therapy. ● Enrollment and dosing of the first patient in the Phase 3 confirmatory study of Marqibo®, named HALLMARQ, in adult patients with newly diagnosed Philadelphia chromosome negative ALL. ● Publication of the Marqibo® RALLY Study in the Journal of Cl..."
01/25/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Talon Therapeutics, Inc. 2010 Equity Incentive Plan, as amended through January 21, 2013"
01/11/2013 8-K Unregistered Sales of Equity Securities
01/07/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Talon Therapeutics, Inc. press release"
01/04/2013 8-K Appointed a new director
11/14/2012 8-K Quarterly results
Docs: "Three Months Ended September 30, 2012 Financial Results For the three months ended September 30, 2012, Talon reported net income of $40.5 million and deemed dividends attributable to preferred stock of $10.7 million, which when combined, resulted in net income applicable to common stockholders of $29.8 million, or $1.35 and $0.18 basic and diluted earnings per share, respectively. This compares to a net loss of $0.7 million and deemed dividends of $1.0 million, which when combined, resulted in a net loss of $1.7 million, or $0.08 per share, for the three months ended September 30, 2011. The change in fair value of Talon’s preferred stockholders’ rights to purchase additional shares of preferred stock contributed $48.0 million, or $2.19 per share, of total net income applicable to common st..."
08/17/2012 8-K Unregistered Sales of Equity Securities
07/18/2012 8-K Entry into a Material Definitive Agreement, Other Events
07/05/2012 8-K Form 8-K - Current report
04/24/2012 8-K Appointed a new director
04/06/2012 8-K Form 8-K - Current report
02/24/2012 8-K Form 8-K - Current report
01/09/2012 8-K Form 8-K - Current report
12/30/2011 8-K Form 8-K - Current report
12/19/2011 8-K Appointed a new director
10/21/2011 8-K Form 8-K - Current report
09/27/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "Press release issued September 27, 2011"
08/19/2011 8-K Form 8-K - Current report
07/19/2011 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Source: Talon Therapeutics, Inc."
07/01/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "Source: Talon Therapeutics, Inc."
01/12/2011 8-K Form 8-K - Current report
12/28/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/02/2010 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Certificate of Ownership merging Talon Therapeutics, Inc. with and into Hana Biosciences, Inc"
09/22/2010 8-K Form 8-K - Current report
09/14/2010 8-K Form 8-K - Current report
09/03/2010 8-K Submission of Matters to a Vote of Security Holders
08/05/2010 8-K Form 8-K - Current report
06/11/2010 8-K Form 8-K - Current report
03/11/2010 8-K Form 8-K - Current report
02/22/2010 8-K Form 8-K - Current report
12/23/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/05/2009 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy